Skip to main content

Table 3 Origins of the DBS used to define the clinical performances of the K13 bMx prototype (from DBS to results) in field conditions

From: A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants

Plasmodium species Clinical status Asia Africa Total
Cambodia Myanmar
Malaria-free 10    10
P. falciparum Symptomatic 296 221 31 548
Asymptomatic 63    63
P. falciparum/P. vivax Symptomatic 17    17
Asymptomatic 2    2
P. vivax Symptomatic 1    1
Asymptomatic 1    1
Total   390 221 31 642